Lorus, F.H. Faulding & Co. Ltd. deal

F.H. Faulding's Faulding (Canada) Inc. subsidiary (Vaudreuil, Quebec) and LOR will co-develop LOR's Virulizin to treat pancreatic cancer in Canada. Faulding (Canada) will have an exclusive six-month ...